When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Acute rhinosinusitis

Última revisão das evidências: 22 Oct 2026
Última atualização do tópico: 04 Aug 2026

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • symptoms <10 days (acute viral rhinosinusitis)
  • symptoms >10 days but <4 weeks (acute bacterial rhinosinusitis)
  • symptoms that worsen after an initial improvement (acute bacterial rhinosinusitis)
  • purulent nasal drainage
  • nasal obstruction
  • facial pain/pressure
  • severe symptoms at onset (acute bacterial rhinosinusitis)
  • dental pain
Detalhes completos

Outros fatores diagnósticos

  • cough
  • sore throat
  • fatigue
  • hyposmia
  • anosmia
  • ear fullness or pressure
  • edematous turbinate
  • fever
Detalhes completos

Fatores de risco

  • viral upper respiratory tract infection
  • allergic rhinitis
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • clinical diagnosis
Detalhes completos

Tests to avoid

  • x-ray paranasal sinuses
Detalhes completos

Investigações a serem consideradas

  • nasal endoscopy
  • sinus culture
  • CT sinuses
  • MRI
  • lateral neck x-ray
  • allergy testing
Detalhes completos

Algoritmo de tratamento

AGUDA

suspected acute viral rhinosinusitis

suspected acute bacterial rhinosinusitis

suspected acute invasive fungal rhinosinusitis

CONTÍNUA

recurrent episodes

Colaboradores

Autores

Gordon H. Sun, MD, MBA, MSc
Gordon H. Sun

Director of Specialty Care

High Desert Health Center Group

Lancaster, CA

Clinical Associate Professor of Otolaryngology-Head and Neck Surgery

Charles R. Drew University of Medicine and Science

Los Angeles, CA

Declarações

GHS is a consultant for MAXIMUS, Inc.

Agradecimentos

Dr Gordon H. Sun would like to gratefully acknowledge Dr Melissa A. Pynnonen and Dr Joseph K. Han, previous contributors to this topic.

Declarações

MAP and JKH declare that they have no competing interests.

Revisores

Michael S. Benninger, MD

Professor of Otolaryngology Head and Neck Surgery

Cleveland Clinic

Lerner College of Medicine

Cleveland

OH

Disclosures

MSB declares that he has no competing interests.

Daniel Merenstein, MD

Director of Research Family Medicine

Georgetown University

Washington, DC

Disclosures

DM declares that he has no competing interests.

Amin R. Javer, MD, FRCSC, FARS

Clinical Professor

Division of Otolaryngology

University of British Columbia

Vancouver

Canada

Disclosures

ARJ is a consultant for iView Therapeutics, GSK, and Sanofi.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Payne SC, McKenna M, Buckley J, et al. Clinical practice guideline: adult sinusitis update. Otolaryngol Head Neck Surg. 2025 Aug;173 Suppl 1:S1-56.Full text  Abstract

Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 Mar;11(3):213-739. Abstract

Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 Feb 20;58(suppl s29):1-464.Full text  Abstract

Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014 Oct;113(4):347-85.Full text

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას